Biopharma - Свежие новости [ Фото в новостях ] | |
Биофарма уходит в крипту: Quantum BioPharma инвестировала $1 млн в цифровые активы
Биофармацевтическая компания Quantum BioPharma объявила о приобретении биткоина и других криптовалют на сумму $1 млн. Интересно, что после этого заявления акции компании на бирже Nasdaq упали почти на 10%. дальше »
2024-12-21 11:09 | |
|
Quantum BioPharma adds $1m in Bitcoin to treasury, eyes future crypto financing
Quantum BioPharma Ltd. , a Nasdaq-listed biotech and medical research company, has purchased $1 million in Bitcoin and other cryptocurrencies as part of a strategic move approved by its board of directors. дальше »
2024-12-21 21:36 | |
|
|
Molecule Partners With VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research
For the first time in history, NFTs are being used for a transfer of IP ownership in medical research. This unique milestone is a result... дальше »
2021-8-19 08:07 | |
|
|
Molecule Partners VitaDAO, Nevermined for Biopharma Research
Molecule, a decentralized biopharma marketplace, has developed a novel IP-to-NFT framework with Web3 technology innovator Nevermined. The post Molecule Partners VitaDAO, Nevermined for Biopharma Research appeared first on BeInCrypto. дальше »
2021-8-19 16:23 | |
|
|
Molecule Partners with VitaDAO and Nevermined Creating First-Ever Biopharma IP-to-NFT Transfer for Longevity Research
Press Release: Molecule, a decentralized biopharma marketplace, has developed a novel IP-to-NFT framework with Web3 technology innovator Nevermined. In a historic transaction, the first biopharma IPNFT was successfully transferred to research collective VitaDAO to fund novel longevity therapeutics at the University of Copenhagen. дальше »
2021-8-18 16:00 | |
|
|
Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research
18th August 2021, Basel, Switzerland — For the first time in history, NFTs are being used for a transfer of IP ownership in medical research. This unique milestone is a result of a partnership between biopharma IP marketplace Molecule, and VitaDAO, a decentralized collective (DAO) funding longevity research, and the University of Copenhagen. This innovationRead More дальше »
2021-8-18 16:00 | |
|
|
Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research
Press Release: Molecule, a decentralised biopharma marketplace, has developed a novel IP-to-NFT framework with Web3 technology innovator Nevermined. In a historic transaction, the first biopharma IPNFT was successfully transferred to research collective VitaDAO to fund novel longevity therapeutics at the University of Copenhagen. дальше »
2021-8-18 16:00 | |
|
|
Molecule, VitaDAO & Nevermined partner to create Biopharma IP-to-NFT transfer
Molecule, a decentralized biopharma marketplace, has developed a novel IP-to-NFT framework with Web3 technology innovator Nevermined. In a historic transaction, the first biopharma IPNFT was successfuThe post Molecule, VitaDAO & Nevermined partner to create Biopharma IP-to-NFT transfer appeared first on AMBCrypto. дальше »
2021-8-18 16:00 | |
|
|
PRNB Stock Up 1% as Sanofi Mulls Buying Principia Biopharma for $50B
Coinspeaker PRNB Stock Up 1% as Sanofi Mulls Buying Principia Biopharma for $50BSanofi is looking at potential acquisitions of U. S. biotechnology companies including Principia Biopharma, as it looks for innovative treatments for clinical areas including multiple sclerosis and immune disorders. дальше »
2020-7-17 18:03 | |
|
|
ALTEN Calsoft uses BlockApps STRATO to launch blockchain for clinical trials
ALTEN Calsoft Labs, an enterprise digital transformation solution and engineering R&D services company, has launched “BioPharma Ledger,” a blockchain clinical trial platform. The newly created blockchain platform for clinical trials will leverage the BlockApps STRATO middleware platform. дальше »
2019-7-9 19:21 | |
|
|
Why Pharma Stock ABIO Skyrocketed a Mind-Blowing 100%
By CCN. com: Biopharmaceutical company ARCA biopharma (NASDAQ: ABIO) led the stock market yesterday with a mind-blowing 98. 64% gain on the day. The ABIO stock price rocketed following an announcement that the company had a critical research paper published in JACC: Heart Failure, part of the Journal of American College of Cardiology. дальше »
2019-5-2 17:37 | |
|
|